🇺🇸 FDA
Patent

US 10588983

Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases

granted A61KA61K2039/505A61K35/768

Quick answer

US patent 10588983 (Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases) held by HALOZYME, INC. expires Mon Mar 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
HALOZYME, INC.
Grant date
Tue Mar 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K2039/505, A61K35/768, A61K38/465, A61K38/47